Medical Imaging Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,164	829.03	682.18	487.29	604.12
Revenue Growth (YoY)	40.45%	21.52%	40.00%	-19.34%	10.66%
Cost of Revenue	813.95	492.93	353.86	247.79	377.02
Gross Profit	350.43	336.09	328.32	239.51	227.1
Selling, General & Admin	124.55	136.46	116.41	93.06	92.23
Operating Expenses	124.51	136.42	116.66	93.11	92.36
Operating Income	225.92	199.67	211.66	146.4	134.75
Interest Expense	-6.9	-2.64	-2.78	-3.38	-3.69
Interest & Investment Income	11.75	5.24	2.13	2.18	2.8
Earnings From Equity Investments	-	-	-	6.66	-30.71
Currency Exchange Gain (Loss)	3.04	0.48	-0.01	1.66	-0.08
Other Non Operating Income (Expenses)	0.39	-0.72	-0.2	-0.12	-0.95
EBT Excluding Unusual Items	234.19	202.04	210.8	153.39	102.12
Gain (Loss) on Sale of Investments	-2.88	-1.99	-43.06	-10.12	-5.68
Gain (Loss) on Sale of Assets	5.02	8.33	0.75	1.24	1.65
Pretax Income	236.33	208.38	168.49	144.5	98.09
Income Tax Expense	50.79	43.36	47.15	32.9	21.32
Net Income	185.54	165.02	121.34	111.6	76.78
Net Income to Common	185.54	165.02	121.34	111.6	76.78
Net Income Growth	12.44%	36.00%	8.72%	45.36%	-20.07%
Shares Outstanding (Basic)	26	23	21	21	21
Shares Outstanding (Diluted)	26	23	22	22	22
Shares Change (YoY)	12.51%	7.38%	-0.07%	-0.01%	0.12%
EPS (Basic)	7.17	7.17	5.66	5.20	3.58
EPS (Diluted)	7.14	7.15	5.64	5.19	3.57
EPS Growth	-0.14%	26.77%	8.67%	45.38%	-19.96%
Free Cash Flow	-322.05	172.14	88.64	211.02	81.99
Free Cash Flow Per Share	-12.40	7.46	4.12	9.80	3.81
Dividend Per Share	4.500	4.000	3.000	2.800	2.000
Dividend Growth	12.50%	33.33%	7.14%	40.00%	-20.00%
Gross Margin	30.10%	40.54%	48.13%	49.15%	37.59%
Operating Margin	19.40%	24.09%	31.03%	30.04%	22.30%
Profit Margin	15.93%	19.91%	17.79%	22.90%	12.71%
Free Cash Flow Margin	-27.66%	20.76%	12.99%	43.30%	13.57%
EBITDA	275.44	248.76	252.56	197.45	188.89
EBITDA Margin	23.66%	30.01%	37.02%	40.52%	31.27%
D&A For EBITDA	49.53	49.09	40.9	51.05	54.15
EBIT	225.92	199.67	211.66	146.4	134.75
EBIT Margin	19.40%	24.09%	31.03%	30.04%	22.30%
Effective Tax Rate	21.49%	20.81%	27.98%	22.77%	21.73%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.